Chronic obstructive pulmonary disease (COPD) 
Introduction

Chronic obstructive pulmonary disease (COPD) is characterized by irreversible airflow limitation in the lungs. Although COPD was the 12th largest disease burden in the world in 1990, it is estimated that it will rise to be the fifth largest disease burden by 2020 (1-4). The most important risk factor for the development of COPD is smoking
. However, only 10-20% of chronic heavy smokers develop symptomatic COPD, which indicates that a difference in susceptibility to tobacco smoke injury must exist and may be related to genetic factors (Fig. 2) (Fig. 1) . 
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Number of studies have been done on the identification of genes that predispose to the development of COPD. Heme oxygenase-1 (HO-1) plays a protective role as an antioxidant in the lung. The length of the (GT)n repeat in the 5'-flanking region of human HO-1 gene polymorphism is associated with susceptibility to COPD (15). The polymorphisms of antioxidant genes glutathione S-transferase M1 (GSTM1) and GSTP1 are reported to be associated with susceptibility to an accelerated decline of lung function in
c) Xenobiotic enzymes and genetics of COPD
Each puff of a cigarette contains 10 17 free radicals and about 4000 substrates including carcinogenic agents and other possible causative agents of COPD such as volatile aldehydes and hydrogen cyanide. Thus, defects in the detoxification of these reactive species may predispose smokers to airflow obstruction and emphysema. It has been suggested that genetic polymorphisms of cytochrome P450, microsomal epoxide hydrolase (mEPHX) are associated with emphysema or COPD (18-20). The genetic polymorphism of exon 5 of smokers with glutathione S-transferase P1 (GSTP 1) is associated with the development of COPD in smokers (3). There is growing evidence for the role of xenobiotics and antioxidant imbalance in the pathogenesis of airflow obstruction, which is supported by association studies between COPD and variants in epoxide hydrolase and GSTs that detoxify free radicals and other tobacco products
d) Other genes associated with the genetic predisposition to COOD
Conclusion and Implication
